This method results in the inclusion of Medicaid prescriptions and gross spending for: Ozempic, Rybelsus, Mounjaro, Victoza, Trulicity, Wegovy, Zepbound, Saxenda, and generic liraglutide as well as a small number of prescriptions and spending for Adlyxin, Byetta, Bydureon BCise, and Tanzeum (now discontinued)
For example: If your hormones are contributing to weight gain, blood testing can identify the issue If you have obesity-related risk factors, your doctor can monitor and treat them If medication is appropriate, GLP-1s like Wegovy can regulate appetite and insulin response Combined with a personalised nutrition and activity plan, this approach supports safe, steady progress without extreme dieting
R., Wang, D., et al
To maintain the results of a weight loss medication, you should expect to continue taking it long-term
NICE recommends prescribing semaglutide 2.4 mg with dietary and physical activity support for adults with weight-related complications (i.e., cardiovascular disease) and BMI 35 kg/m 2 (or exceptionally 30) within specialist services [5]
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist: A phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
